GL Sciences
7705.T
Financials · Consolidated
| Fiscal year ended | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 | 2019-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥37.1bn | ¥38.7bn | ¥33.1bn | ¥29.2bn | ¥25.5bn | ¥24.8bn |
| Operating income | ¥5.7bn | ¥6.0bn | ¥4.8bn | ¥3.8bn | — | — |
| Ordinary income | ¥6.1bn | ¥6.5bn | ¥5.0bn | ¥3.9bn | ¥2.8bn | ¥3.1bn |
| Net income (owners) | ¥3.4bn | ¥3.5bn | ¥2.8bn | ¥2.3bn | ¥1.6bn | ¥2.0bn |
| Total assets | ¥55.6bn | ¥51.0bn | ¥43.0bn | ¥38.7bn | ¥33.1bn | ¥32.1bn |
| Net assets / equity | ¥40.2bn | ¥35.6bn | ¥31.5bn | ¥27.8bn | ¥24.7bn | ¥23.5bn |
| Operating cash flow | ¥3.5bn | ¥2.0bn | ¥3.7bn | ¥2.7bn | ¥2.2bn | ¥2.1bn |
| EPS (basic) | ¥334.38 | ¥341.05 | ¥272.45 | ¥220 | ¥159.21 | ¥195.54 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 9
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2024-03-31 | Annual | 205 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 49 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 205 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 49 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 205 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2024-03
| Segment | External sales | Profit |
|---|---|---|
| Analytical Equipment | ¥18.3bn | ¥2.0bn |
| Automatic Identification | ¥1.8bn | ¥135m |
| Semiconductor | ¥17.0bn | ¥3.6bn |
| Adjustments & eliminations | — | ¥1m |
| Total | ¥37.1bn | ¥5.7bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.